JMP Securities Downgrades Globus Medical (GMED) to Market Perform
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.
JMP Securities downgraded Globus Medical (NYSE: GMED) from Market Outperform to Market Perform.
Shares of Globus Medical closed at $22.33 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Stifel Downgrades PennTex Midstream Partners, LP (PTXP) to Hold
- UPDATE: Stifel Downgrades Arc Logistics Partners (ARCX) to Hold
- Stifel Downgrades Cott Corporation (COT) to Hold
Create E-mail Alert Related CategoriesDowngrades
Related EntitiesJMP Securities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!